Literature DB >> 1693076

Neoantigens in complement component C3 as detected by monoclonal antibodies. Mapping of the recognized epitopes by synthetic peptides.

B Nilsson1, K Nilsson Ekdahl, D Avila, U R Nilsson, J D Lambris.   

Abstract

The different fragments of the third complement component, C3, generated upon complement activation/inactivation have the ability to bind to several other complement components and receptors as well as to proteins of foreign origin. These multiple reactivities of C3 fragments are associated with a series of conformational changes occurring in the C3 molecule during its degradation. The conformations acquired by the different C3 fragments are also associated with the exposure of neoantigenic epitopes that are specific for (a) particular fragment(s). In order to study these epitopes and thus the conformational changes occurring in C3, monoclonal antibodies (mAbs) recognizing such epitopes were produced in Balb/c mice after immunization with denatured human C3. Two of the three antibodies (7D84.1 and 7D264.6) presented in this study recognized predominantly surface-bound iC3b, and one mAb (7D323.1) recognized both surface-bound and fluid-phase iC3b. Although none of the mAbs recognized any other fluid-phase C3 fragment, all three antibodies detected micro-titre-plate-fixed C3b and iC3b, but not C3c or C3d. In addition to the reaction with human C3, mAb 7D323.1 also bound to micro-titre-plate-fixed rabbit C3. The epitopes recognized by the three mAbs were further localized by using synthetic peptides that were designed on the basis of the differential binding of the mAbs to the C3 fragments. All three antibodies reacted with C3-(924-965)-peptide, which represents the region of C3 between the kallikrein-cleavage site (923-924) and the elastase-cleavage site (965-966). On the basis of the binding of the mAbs to five different overlapping peptides spanning the region between residues 924 and 965 of the human C3 sequence, and the sequence similarity between human C3 and rabbit C3 within this area, the epitopes recognized by these antibodies are mapped. The contribution of the individual amino acid residues in the formation of the epitopes is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1693076      PMCID: PMC1131390          DOI: 10.1042/bj2680055

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  48 in total

1.  Characterization of tryptic fragments of human complement factor C3.

Authors:  G Eggertsen; U Hellman; A Lundwall; J Folkersen; J Sjöquist
Journal:  Mol Immunol       Date:  1985-08       Impact factor: 4.407

2.  Identification of functionally relevant determinants on the complement component C3 with monoclonal antibodies.

Authors:  R Burger; U Deubel; U Hadding; D Bitter-Suermann
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

3.  Kinetic and thermodynamic analysis of the control of C3b by the complement regulatory proteins factors H and I.

Authors:  M K Pangburn; H J Müller-Eberhard
Journal:  Biochemistry       Date:  1983-01-04       Impact factor: 3.162

4.  The binding of human complement proteins C5, factor B, beta 1H and properdin to complement fragment C3b on zymosan.

Authors:  R G DiScipio
Journal:  Biochem J       Date:  1981-12-01       Impact factor: 3.857

5.  Selective inhibition of functional sites of cell-bound C3b by hybridoma-derived antibodies.

Authors:  J D Tamerius; M K Pangburn; H J Müller-Eberhard
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

6.  Human C3 and C5: subunit structure and modifications by trypsin and C42-C423.

Authors:  U R Nilsson; R J Mandle; J A McConnell-Mapes
Journal:  J Immunol       Date:  1975-02       Impact factor: 5.422

7.  Location of the inter-chain disulfide bonds of the third component of human complement.

Authors:  T Matsuda; T Seya; S Nagasawa
Journal:  Biochem Biophys Res Commun       Date:  1985-02-28       Impact factor: 3.575

8.  Suppression of T lymphocyte functions by human C3 fragments. I. Inhibition of human T cell proliferative responses by a kallikrein cleavage fragment of human iC3b.

Authors:  J L Meuth; E L Morgan; R G DiSipio; T E Hugli
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

9.  Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms.

Authors:  D T Fearon; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

10.  The role of C4-binding protein and beta 1H in proteolysis of C4b and C3b.

Authors:  T Fujita; V Nussenzweig
Journal:  J Exp Med       Date:  1979-08-01       Impact factor: 14.307

View more
  11 in total

1.  Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement.

Authors:  Tommi Kajander; Markus J Lehtinen; Satu Hyvärinen; Arnab Bhattacharjee; Elisa Leung; David E Isenman; Seppo Meri; Adrian Goldman; T Sakari Jokiranta
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-01       Impact factor: 11.205

2.  Phosphorylation of complement component C3 after synthesis in U937 cells by a putative protein kinase, casein kinase 2, which is regulated by CD11b: evidence that membrane-bound proteases preferentially cleave phosphorylated C3.

Authors:  K Nilsson Ekdahl; B Nilsson
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

3.  Alterations in immunodominance of Streptococcus mutans AgI/II: lessons learned from immunomodulatory antibodies.

Authors:  Rebekah A Robinette; Kyle P Heim; Monika W Oli; Paula J Crowley; William P McArthur; L Jeannine Brady
Journal:  Vaccine       Date:  2013-11-16       Impact factor: 3.641

4.  Purification and characterization of IgG immunoconglutinins from patients with systemic lupus erythematosus: implications for a regulatory function.

Authors:  B Nilsson; K N Ekdahl; M Svarvare; A Bjelle; U R Nilsson
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

5.  A Robust Method to Store Complement C3 With Superior Ability to Maintain the Native Structure and Function of the Protein.

Authors:  Anna Adler; Vivek Anand Manivel; Karin Fromell; Yuji Teramura; Kristina N Ekdahl; Bo Nilsson
Journal:  Front Immunol       Date:  2022-05-03       Impact factor: 8.786

6.  Conformational differences between surface-bound and fluid-phase complement-component-C3 fragments. Epitope mapping by cDNA expression.

Authors:  B Nilsson; D Grossberger; K Nilsson Ekdahl; P Riegert; D J Becherer; U R Nilsson; J D Lambris
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

7.  Evidence for iC3 generation during cardiopulmonary bypass as the result of blood-gas interaction.

Authors:  M Pekna; L Nilsson; K Nilsson-Ekdahl; U R Nilsson; B Nilsson
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

8.  Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c.

Authors:  S B Laursen; S Thiel; B Teisner; U Holmskov; Y Wang; R B Sim; J C Jensenius
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

9.  Two conformational forms of target-bound iC3b that distinctively bind complement receptors 1 and 2 and two specific monoclonal antibodies.

Authors:  Ulf R Nilsson; Lillemor Funke; Bo Nilsson; Kristina N Ekdahl
Journal:  Ups J Med Sci       Date:  2010-11-11       Impact factor: 2.384

10.  Mesenchymal stromal cells engage complement and complement receptor bearing innate effector cells to modulate immune responses.

Authors:  Guido Moll; Regina Jitschin; Lena von Bahr; Ida Rasmusson-Duprez; Berit Sundberg; Lena Lönnies; Graciela Elgue; Kristina Nilsson-Ekdahl; Dimitrios Mougiakakos; John D Lambris; Olle Ringdén; Katarina Le Blanc; Bo Nilsson
Journal:  PLoS One       Date:  2011-07-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.